Synergy CHC Corp. Q1 2025 Update: Revenue Declines but Net Income Rises Amid Financial Challenges

Synergy CHC Corp. (OTCBB: SNYR) - Q1 2025 Financial Update

Overview:
Synergy CHC Corp. is a consumer health care company primarily engaged in the development of best-in-class brands within the nutraceutical sector. The fiscal year ended on March 31, 2025, showcases both challenges and opportunities for Synergy as it navigates its financial landscape.

Positive Aspects: Income Statement Highlights
- Total revenue for Q1 2025 was $8,170,534 compared to $9,411,863 in Q1 2024, indicating a notable performance driven by a new license revenue stream of $1,500,000.
- Gross profit stood at $6,164,021, maintaining a healthy gross margin of 75%, which is an increase from 72% year-over-year.
- Net income increased to $876,264 from $580,530 year-over-year.
- Basic and diluted earnings per share rose to $0.10, a positive outlook for shareholders.

Negative Aspects: Income Statement Highlights
- Product sales declined significantly from $9,411,863 to $6,670,534, marking a decrease of about $2.7 million.
- Operating expenses were reduced to $4,216,318, but selling and marketing expenses remained high at $2,876,271, emphasizing a need for cost management in promotions.
- The accumulated deficit stands at $43,223,549, highlighting financial pressure in the company’s capital structure.
- Cash and cash equivalents dwindled to $177,882 from $687,920, raising potential liquidity concerns.

Key Statistics:
- Revenue: $8,170,534
- Cost of Sales: $2,006,513
- Gross Profit: $6,164,021
- Net Income: $876,264
- Total Assets: $15,656,042
- Total Liabilities: $31,295,408
- Accumulated Deficit: $(43,223,549)
- Weighted Average Shares Outstanding (Basic): 8,560,636
- Earnings Per Share (Basic & Diluted): $0.10

Recent Developments:
- The company engaged in several negotiations to refinance existing debt, potentially alleviating immediate financial pressures.
- Debt repaid during Q1 included $1.3 million, showcasing steps towards reducing liabilities.
- Comprehensive income reported in Q1 2025 was $874,329, slightly below comprehensive income of $712,167 in Q1 2024.

Looking Ahead:
Synergy CHC Corp. aims to bridge its revenue gap through strategic product expansions and potential acquisitions while continuing to manage operational costs effectively. Investors should monitor the company's ability to leverage new revenue streams against its high operational expenses.

For continuous updates on financial performance, explore more about Synergy CHC Corp. on their official trading platform.